- Home
- CODX vs LSB Comparison
CODX vs LSB Comparison
Compare CODX & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- LSB
- Stock Information
- Founded
- CODX 2013
- LSB 2002
- Country
- CODX United States
- LSB China
- Employees
- CODX N/A
- LSB N/A
- Industry
- CODX Medical/Dental Instruments
- LSB
- Sector
- CODX Health Care
- LSB
- Exchange
- CODX Nasdaq
- LSB NYSE
- Market Cap
- CODX 39.3M
- LSB 41.2M
- IPO Year
- CODX 2017
- LSB N/A
- Fundamental
- Price
- CODX $1.06
- LSB $2.60
- Analyst Decision
- CODX Hold
- LSB
- Analyst Count
- CODX 1
- LSB 0
- Target Price
- CODX $1.50
- LSB N/A
- AVG Volume (30 Days)
- CODX 90.9K
- LSB 73.7K
- Earning Date
- CODX 11-07-2024
- LSB 11-29-2024
- Dividend Yield
- CODX N/A
- LSB N/A
- EPS Growth
- CODX N/A
- LSB N/A
- EPS
- CODX N/A
- LSB N/A
- Revenue
- CODX $7,321,012.00
- LSB $79,415,311.00
- Revenue This Year
- CODX N/A
- LSB $39.33
- Revenue Next Year
- CODX N/A
- LSB $75.61
- P/E Ratio
- CODX N/A
- LSB N/A
- Revenue Growth
- CODX 57.16
- LSB N/A
- 52 Week Low
- CODX $1.00
- LSB $1.88
- 52 Week High
- CODX $2.23
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- CODX 34.55
- LSB 43.52
- Support Level
- CODX $1.02
- LSB $2.36
- Resistance Level
- CODX $1.09
- LSB $2.79
- Average True Range (ATR)
- CODX 0.05
- LSB 0.48
- MACD
- CODX -0.01
- LSB 0.12
- Stochastic Oscillator
- CODX 21.74
- LSB 46.15
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.